StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE – Free Report) in a report issued on Wednesday. The brokerage issued a sell rating on the stock.
Ampio Pharmaceuticals Stock Performance
AMPE stock opened at $0.00 on Wednesday. The stock has a market capitalization of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a 12 month low of $0.00 and a 12 month high of $7.47.
Ampio Pharmaceuticals Company Profile
Want More Great Investing Ideas?
Featured Stories
- Five stocks we like better than Ampio Pharmaceuticals
- How to Calculate Inflation Rate
- Boeing: Why Analysts Think Now’s The Time To Be Brave
- How to Use High Beta Stocks to Maximize Your Investing Profits
- Advanced Micro Devices is Building Momentum with AI: Buy the Dip
- 3 REITs to Buy and Hold for the Long Term
- Can Evolv Stock Recover From Its Massive Self-Inflicted Drop?
Receive News & Ratings for Ampio Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampio Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
